Dr. Cecelia Constance Damask , DO
Otolaryngology • Orlando, FL
11317 Lake Underhill Rd Ste 100
Orlando, FL 328254452
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 27, 2006; this date does not establish years in practice.
-
Published CMS data list 327 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 85 service units.
- 99213 — Established patient outpatient office visit: 83 service units.
- 69210 — Removal of impacted ear wax: 49 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 277 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Fluticasone Propionate — 57 prescription fills, including refills.
- Ipratropium Bromide — 42 prescription fills, including refills.
- Epinephrine — 36 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 10 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 80% of clinicians listed under Otolaryngology in Florida (2024, 431 clinicians with data). Median for this group: 1,125. Middle half: 426 to 2,865.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,934 in 2020 to 327 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
11317 Lake Underhill Rd Ste 100
Orlando, FL 328254452
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Florida Ent Associates Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
1993
What Public CMS Data Show
Otolaryngology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
173 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $30,332 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $22,125 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
394 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$36,426 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $183,233.32 across 198 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $149,958.66 across 36 records.
- Travel and Lodging: $17,890.25 across 41 records.
- Consulting Fee: $10,740.00 across 9 records.
Reporting-company totals (3 largest of 16)
- Sanofi and Genzyme US Companies: $75,593.70 across 47 records.
- Regeneron Pharmaceuticals, Inc.: $45,656.46 across 43 records.
- GlaxoSmithKline, LLC.: $36,921.21 across 37 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
33 years (graduated 1993)
CMS Doctors and Clinicians data list 1993 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Damask has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Damask as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Orlando and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 80% of clinicians listed under Otolaryngology in Florida (2024, 431 clinicians with data). Median for this group: 1,125. Middle half: 426 to 2,865.
Too few clinicians listed under Otolaryngology in Orlando have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 80% of clinicians listed under Otolaryngology in Florida (2024, 431 clinicians with data). Median for this group: $115,067. Middle half: $49,721 to $227,899.
Too few clinicians listed under Otolaryngology in Orlando have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 80% of clinicians listed under Otolaryngology in Florida (2024, 431 clinicians with data). Median for this group: $85,698. Middle half: $36,437 to $172,567.
Too few clinicians listed under Otolaryngology in Orlando have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Otolaryngology in Florida (2024, 442 clinicians with data). Median for this group: 607. Middle half: 156 to 1,245.
Too few clinicians listed under Otolaryngology in Orlando have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Otolaryngology in Florida (2024, 442 clinicians with data). Median for this group: $12,720. Middle half: $2,909 to $35,978.
Too few clinicians listed under Otolaryngology in Orlando have Medicare Part D data for 2024 to compare.
18 active clinicians are listed under Otolaryngology with a practice address in Orlando, FL (664 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Orlando
5.6% of these 18 clinicians have the CMS telehealth indicator.
55.6% of these 18 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 89% from 2,934 in 2020 to 327 in 2024.
- 2020: 2,934
- 2021: 2,552
- 2022: 1,952
- 2023: 327
- 2024: 327
-
Medicare-allowed amount
Medicare-allowed amount decreased 63% from $82,582 in 2020 to $30,332 in 2024.
- 2020: $82,582
- 2021: $84,156
- 2022: $76,721
- 2023: $27,263
- 2024: $30,332
-
Paid by Medicare
Paid by Medicare decreased 61% from $56,714 in 2020 to $22,125 in 2024.
- 2020: $56,714
- 2021: $61,537
- 2022: $53,784
- 2023: $18,440
- 2024: $22,125
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 68% from 867 in 2020 to 277 in 2024.
- 2020: 867
- 2021: 767
- 2022: 639
- 2023: 393
- 2024: 277
-
30-day fills
30-day fills decreased 66% from 1,152 in 2020 to 394 in 2024.
- 2020: 1,152
- 2021: 1,002
- 2022: 950
- 2023: 570
- 2024: 394
-
Part D drug cost
Part D drug cost decreased 83% from $209,430 in 2020 to $36,426 in 2024.
- 2020: $209,430
- 2021: $226,375
- 2022: $145,007
- 2023: $54,345
- 2024: $36,426
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 135% from $77,943.72 in 2021 to $183,233.32 in 2025.
- 2021: $77,943.72
- 2022: $70,938.68
- 2023: $89,887.87
- 2024: $205,422.19
- 2025: $183,233.32
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 198 records totaling $183,233.32.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $11,725.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $10,816.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $10,400.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $10,400.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $10,400.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $9,152.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $7,973.00 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $4,800.00 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $4,800.00 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $4,800.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $4,221.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $4,221.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $3,744.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $3,744.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $3,744.00 |
| Optinose US, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Xhance | General | $3,300.00 |
| Optinose US, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Xhance | General | $3,300.00 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $3,200.00 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $3,200.00 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $3,200.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $2,912.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $2,912.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $2,657.66 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
TEZSPIRE | General | $2,416.50 |
| GlaxoSmithKline, LLC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NUCALA | General | $2,400.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
85 | 65 | $300.62 | $124.59 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
83 | 62 | $279.42 | $88.04 |
|
69210
Removal of impacted ear wax
|
49 | 27 | $116.00 | $46.76 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
42 | 42 | $266.00 | $108.81 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
29 | 29 | $393.14 | $163.59 |
|
94010
Test to measure expiratory airflow and volume
|
15 | 13 | $68.00 | $25.90 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
12 | 12 | $106.00 | $36.70 |
|
J7613
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
|
12 | 12 | $2.25 | $0.06 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Fluticasone Propionate | Fluticasone Propionate | 57 | 3,660 | $1,180.55 | 26 |
| Ipratropium Bromide | Ipratropium Bromide | 42 | 1,296 | $1,923.73 | 20 |
| Epinephrine | Epinephrine | 36 | 632 | $5,783.13 | 33 |
| Symbicort | Budesonide/Formoterol Fumarate | 30 | 1,140 | $8,999.91 | — |
| Advair Hfa | Fluticasone Propion/Salmeterol | 28 | 900 | $8,699.20 | — |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 22 | 546 | $494.45 | 15 |
| Betamethasone Valerate | Betamethasone Valerate | 19 | 350 | $323.47 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | 540 | $6,945.05 | — |
| Azelastine Hcl | Azelastine Hcl | 13 | 1,000 | $1,002.92 | — |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | 540 | $1,073.85 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-06-16NUCC Taxonomy Code: 207Y00000X
An otolaryngologist-head and neck surgeon provides comprehensive medical and surgical care for patients with diseases and disorders that affect the ears, nose, throat, the respiratory and upper alimentary systems and related structures of the head and neck. An otolaryngologist diagnoses and provides medical and/or surgical therapy or prevention of diseases, allergies, neoplasms, deformities, disorders and/or injuries of the ears, nose, sinuses, throat, respiratory and upper alimentary systems, face, jaws and the other head and neck systems. Head and neck oncology, facial plastic and reconstructive surgery and the treatment of disorders of hearing and voice are fundamental areas of expertise.
NUCC Taxonomy Code: 207YX0602X
An otolaryngologist who specializes in the diagnosis and treatment of otolaryngic allergies and other allergic diseases.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OTOLARYNGOLOGY
I20050207000627
NC
7719938745
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Florida Ent Associates Inc
11317 Lake Underhill Rd, Orlando, FL 328254452
Phone: 4079554948
Florida Ent Associates Inc
160 E Lake Howard Dr, Winter Haven, FL 338813155
Phone: 8632991251
Florida Ent Associates Inc
5830 Lake Underhill Rd, Orlando, FL 328074311
Phone: 4076580228
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine - Geriatric Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 11317 LAKE UNDERHILL RD STE 100, ORLANDO, FL 328254452 (Tel: 4079554948)
Registered at 15280 NW 79TH CT STE 200, MIAMI LAKES, FL 330165873 (Tel: 3055583724)
Otolaryngology (license number reported to NPPES: FL OS9704)
NPI status registered as active in NPPES database
Registered at 795 PRIMERA BLVD, SUITE 1031, LAKE MARY, FL 327462191 (Tel: 4078298981)
Registered at 795 PRIMERA BLVD, SUITE 1031, LAKE MARY, FL 327462191 (Tel: 4078298981)
Recorded as CECELIA DAMASK, DO
Otolaryngology (license number reported to NPPES: FL OS9704)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Otolaryngology Specialists in Orlando
- Dr. Bradley Reese, MD
- Dr. Halla Shami Sher, MD
- Dr. Jared Shenson, MD
- Dr. Adnan Hussaini, MD
- Dr. Lisa Waizenegger, MD
- Dr. Dale Harrington, DO
Mailing Address
15280 Nw 79th Ct Ste 200
Miami Lakes, FL 330165873
Phone: 3055583724